| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.08 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.09 |